Literature DB >> 9481807

Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP.

M K Spearing1, R M Post, G S Leverich, D Brandt, W Nolen.   

Abstract

The Clinical Global Impressions Scale (CGI) was modified specifically for use in assessing global illness severity and change in patients with bipolar disorder. Criticisms of the original CGI were addressed by correcting inconsistencies in scaling, identifying time frames for comparison, clarifying definitions of illness severity and change, and separating out assessment of treatment side effects from illness improvement during treatment. A Detailed User's Guide was developed to train clinicians in the use of the new CGI-Bipolar Version (CGI-BP) for rating severity of manic and depressive episodes and the degree of change from the immediately preceding phase and from the worst phase of illness. The revised scale and manual provide a focused set of instructions to facilitate the reliability of these ratings of mania, depression, and overall bipolar illness during treatment of an acute episode or in longer-term illness prophylaxis. Interrater reliability of the scale was demonstrated in preliminary analyses. Thus, the modified CGI-BP is anticipated to be more useful than the original CGI in studies of bipolar disorder.

Entities:  

Mesh:

Year:  1997        PMID: 9481807     DOI: 10.1016/s0165-1781(97)00123-6

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  222 in total

Review 1.  An overview of mood disorders in the DSM-5.

Authors:  Jan Fawcett
Journal:  Curr Psychiatry Rep       Date:  2010-12       Impact factor: 5.285

2.  Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment - Moderate dose Use Study (LiTMUS) for bipolar disorder.

Authors:  Louisa G Sylvia; Noreen A Reilly-Harrington; Andrew C Leon; Christine I Kansky; Terence A Ketter; Joseph R Calabrese; Michael E Thase; Charles L Bowden; Edward S Friedman; Michael J Ostacher; Dan V Iosifescu; Joanne Severe; Michelle Keyes; Andrew A Nierenberg
Journal:  Clin Trials       Date:  2011-11-10       Impact factor: 2.486

3.  The clinical global impressions scale: applying a research tool in clinical practice.

Authors:  Joan Busner; Steven D Targum
Journal:  Psychiatry (Edgmont)       Date:  2007-07

4.  Efficacy and Safety of Once- versus Twice-Daily Carbamazepine Extended-Release Capsules for the Treatment of Manic Symptoms in Patients with Bipolar I Disorder.

Authors:  Richard H Weisler; Amir H Kalali; Andrew J Cutler; Thomas D Gazda; Lawrence Ginsberg
Journal:  Psychiatry (Edgmont)       Date:  2008-03

5.  Non-Suicidal Self-Injury in Pediatric Bipolar Disorder: Clinical Correlates and Impact on Psychosocial Treatment Outcomes.

Authors:  Heather A MacPherson; Sally M Weinstein; Amy E West
Journal:  J Abnorm Child Psychol       Date:  2018-05

6.  Effectiveness of lamotrigine in maintaining symptom control in pediatric bipolar disorder.

Authors:  Mani N Pavuluri; David B Henry; Melissa Moss; Tahseen Mohammed; Julie A Carbray; John A Sweeney
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-02       Impact factor: 2.576

7.  Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation.

Authors:  Daniel P Dickstein; Kenneth E Towbin; Jan Willem Van Der Veen; Brendan A Rich; Melissa A Brotman; Lisa Knopf; Laura Onelio; Daniel S Pine; Ellen Leibenluft
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-02       Impact factor: 2.576

8.  Trait-related alterations of N-acetylaspartate in euthymic bipolar patients: A longitudinal proton magnetic resonance spectroscopy study.

Authors:  Burç Aydin; Ayşegül Yurt; Necati Gökmen; Perry Renshaw; David Olson; Ayşegül Yildiz
Journal:  J Affect Disord       Date:  2016-09-09       Impact factor: 4.839

9.  An Integrated Risk Reduction Intervention can reduce body mass index in individuals being treated for bipolar I disorder: results from a randomized trial.

Authors:  Ellen Frank; Meredith L Wallace; Martica Hall; Brant Hasler; Jessica C Levenson; Carol A Janney; Isabella Soreca; Matthew C Fleming; Joan Buttenfield; Fiona C Ritchey; David J Kupfer
Journal:  Bipolar Disord       Date:  2014-12-12       Impact factor: 6.744

10.  Assessing the affective load in the narratives of women suffering from fibromyalgia: the clinicians' appraisal.

Authors:  Christine Cedraschi; Elodie Girard; Valérie Piguet; Jules Desmeules; Anne-Françoise Allaz
Journal:  Health Expect       Date:  2014-12-10       Impact factor: 3.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.